The recombinant catalytic domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP-2

FEBS Letters
A LichteH Tschesche

Abstract

A truncated form of the membrane-type matrix metalloproteinase-1 [(Ala21-Ile318)proMT1-MMP] lacking the hemopexin-like and trans-membrane domain was produced in E. coli. We demonstrate that the recombinant proenzyme was autoproteolytically processed to a fully active catalytic domain with N-terminal Ile114. The catalytic domain of MT1-MMP initiated the activation of progelatinase A and progelatinase A complexed with tissue inhibitor of metalloproteinases-2 (TIMP-2). As a typical soluble metalloproteinase it was able to cleave physiologic as well as synthetic substrates. Our kinetic data demonstrate that TIMP-2 is a potent inhibitor for the recombinant enzyme.

References

Mar 1, 1978·European Journal of Biochemistry·R TimplH Wiedemann
Jul 1, 1992·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·L M Matrisian
Aug 1, 1991·Biochemical Society Transactions·H NagaseG Salvesen
Jan 1, 1990·Methods in Enzymology·F W StudierJ W Dubendorff
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·C S HEG I Goldberg
Aug 31, 1982·Biochemical and Biophysical Research Communications·H Birkedal-Hansen, R E Taylor
Feb 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·E CrouchP Bornstein
Sep 1, 1994·Biological Chemistry Hoppe-Seyler·H KolkenbrockN Ulbrich
Oct 15, 1993·The Biochemical Journal·V KnäuperH Tschesche
Jan 1, 1993·Annual Review of Cell Biology·W G Stetler-StevensonL A Liotta
Jan 1, 1993·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·H Birkedal-HansenJ A Engler
Oct 1, 1995·Current Opinion in Cell Biology·H Birkedal-Hansen

❮ Previous
Next ❯

Citations

Oct 3, 2003·Biochimica Et Biophysica Acta·Satoshi KubotaHaruhiko Toyohara
Mar 24, 2010·The Journal of Biological Chemistry·Ilian A RadichevAlex Y Strongin
Jul 29, 2011·The Journal of Biological Chemistry·Kevin ZarrabiJian Cao
Nov 13, 1998·Current Opinion in Lipidology·S J George
Jul 23, 1999·Annals of the New York Academy of Sciences·O TeronenT Sorsa
Mar 18, 2000·Biological Chemistry·H KolkenbrockN Ulbrich
Dec 4, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Margaret W NdinguriGregg B Fields
Sep 29, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T HagemannC Binder
Sep 10, 2005·International Journal of Cancer. Journal International Du Cancer·Alexander MargulisJonathan A Garlick
Jul 27, 2000·Protein Expression and Purification·M RoderfeldH Tschesche
Jun 23, 2015·Genes & Diseases·Jillian CathcartJian Cao
Mar 22, 2015·Matrix Biology : Journal of the International Society for Matrix Biology·Yoshifumi Itoh
Mar 21, 2001·Biotechnology & Genetic Engineering Reviews·L M BabéB F Schmidt
Sep 1, 1997·Current Eye Research·A Smine, J J Plantner
Jan 16, 2002·The Journal of Biological Chemistry·M Margarida BernardoShahriar Mobashery
Jul 9, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·K M SouthgateG D Angelini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.